Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS

v3.4.0.3
DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS
 9 Months Ended
Mar. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities Disclosure [Text Block]
NOTE 10 - DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS
 
Derivative Financial Instruments:
 
The Company applies the provisions of ASC Topic 815-40, Contracts in Entity’s Own Equity (“ASC Topic 815-40”), under which convertible instruments and warrants, which contain terms that protect holders from declines in the stock price (reset provisions), may not be exempt from derivative accounting treatment. As a result, warrants and embedded conversion options in convertible debt are recorded as a liability and are revalued at fair value at each reporting date. If the fair value of the warrants exceeds the face value of the related debt, the excess is recorded as change in fair value in operations on the issuance date. The Company has 3,000,000 warrants and $2,922,199 of convertible debt with repricing options qualifying for derivative accounting treatment outstanding at March 31, 2016.
 
The Company calculates the estimated fair values of the liabilities for derivative instruments using the Black Scholes (“BSM”) option pricing model. The closing price of the Company’s common stock at March 31, 2016 was $0.0304. Volatility, expected remaining term and risk free interest rates used to estimate the fair value of derivative liabilities at March 31, 2016, are indicated in the table that follows. The volatility was based on historical volatility at March 31, 2016, the expected term is equal to the remaining term of the warrants and the risk free rate is based upon rates for treasury securities with the same term.
 
Warrants
 
 
 
March 31, 2016
 
Volatility
 
 
217
%
Expected remaining term
 
 
2.50
 
Risk-free interest rate
 
 
1.31
%
Expected dividend yield
 
 
none
 
 
Convertible Debt
 
 
 
Initial Valuations
(on new
derivative
instruments
entered into during
the three months
ended March
31, 2016)
 
 
March 31,
2016
 
Volatility
 
 
217
%
 
 
217
%
Expected Remaining Term
 
 
0.70
 
 
 
0.58
 
Risk Free Interest Rate
 
 
0.7
%
 
 
0.6
%
Expected dividend yield
 
 
none
 
 
 
none
 
 
Fair Value Measurements:
 
The Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable warrants and embedded conversion options have been recorded as determined utilizing the BSM option pricing model. The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2016:
 
 
 
Balance at
 
Quoted Prices
 
Significant
 
 
 
 
 
 
March
 
in Active
 
Other
 
Significant
 
 
 
31,
 
Markets for
 
Observable
 
Unobservable
 
 
 
2016
 
Identical Assets
 
Inputs
 
Inputs
 
 
 
 
 
 
 
(Level 1)
 
 
(Level 2)
 
 
(Level 3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Embedded conversion option liabilities
 
$
3,659,506
 
$
—
 
$
—
 
$
3,659,506
 
Fair value of liability for warrant derivative instruments
 
$
80,630
 
$
—
 
$
—
 
$
80,630
 
Total
 
$
3,740,136
 
$
—
 
$
—
 
$
3,740,136
 
 
The following is a roll forward for the nine months ended March 31, 2016 of the fair value liability of price adjustable derivative instruments:
 
 
 
Fair Value of
 
 
 
Liability for
 
 
 
Derivative
 
 
 
Instruments
 
 
 
 
 
 
Balance at June 30, 2015
 
$
1,049,929
 
Effects of foreign currency exchange rate changes
 
 
(10,490)
 
Initial fair value of embedded conversion option derivative liability recorded as debt discount
 
 
2,205,925
 
Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO
 
 
2,211,529
 
Change in fair value included in statements of operations
 
 
(1,716,757)
 
Balance at March 31, 2016
 
$
3,740,136